- Home
- KROS vs MHD Comparison
KROS vs MHD Comparison
Compare KROS & MHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- MHD
- Stock Information
- Founded
- KROS 2015
- MHD N/A
- Country
- KROS United States
- MHD United States
- Employees
- KROS N/A
- MHD N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- MHD Investment Bankers/Brokers/Service
- Sector
- KROS Health Care
- MHD Finance
- Exchange
- KROS Nasdaq
- MHD Nasdaq
- Market Cap
- KROS 460.6M
- MHD 631.4M
- IPO Year
- KROS 2020
- MHD N/A
- Fundamental
- Price
- KROS $11.00
- MHD $12.16
- Analyst Decision
- KROS Buy
- MHD
- Analyst Count
- KROS 11
- MHD 0
- Target Price
- KROS $45.33
- MHD N/A
- AVG Volume (30 Days)
- KROS 2.1M
- MHD 124.9K
- Earning Date
- KROS 02-26-2025
- MHD 01-01-0001
- Dividend Yield
- KROS N/A
- MHD 4.16%
- EPS Growth
- KROS N/A
- MHD N/A
- EPS
- KROS N/A
- MHD N/A
- Revenue
- KROS $651,000.00
- MHD N/A
- Revenue This Year
- KROS $303.27
- MHD N/A
- Revenue Next Year
- KROS N/A
- MHD N/A
- P/E Ratio
- KROS N/A
- MHD N/A
- Revenue Growth
- KROS 8037.50
- MHD N/A
- 52 Week Low
- KROS $9.78
- MHD $9.92
- 52 Week High
- KROS $73.00
- MHD $12.18
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- MHD 59.99
- Support Level
- KROS $11.04
- MHD $12.00
- Resistance Level
- KROS $11.99
- MHD $12.05
- Average True Range (ATR)
- KROS 0.60
- MHD 0.12
- MACD
- KROS 1.20
- MHD 0.04
- Stochastic Oscillator
- KROS 43.99
- MHD 74.49
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About MHD Blackrock MuniHoldings Fund Inc.
Blackrock Muniholdings Fund Inc is a closed-end management investment company. The fund's objective is to provide shareholders with current income exempt from U.S. federal income taxes. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.